Disease · MONDO_0100192
Trials12
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 3 more are not shown, since the checks do not confirm them.
1 to 12 of 12
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02193867 | Clinical Study In Infants With Rapidly Progressive Lysosomal Acid Lipase Deficiency | Phase 2 | 10 | 2019-11-18 | Lysosomal Acid Lipase Deficiency | SEBELIPASE ALFA | Its record names the disease | ClinicalTrials.gov |
| NCT00162552 | Clinical Trial of Pentoxifylline in Patient With Cirrhosis | Phase 3 | 342 | Cirrhosis, Liver Failure | PENTOXIFYLLINE | Its record names the disease | ClinicalTrials.gov | |
| NCT01997658 | Preoperative Glucocorticoid Use in Major Hepatectomy | Phase 2/3 | 200 | Complications | METHYLPREDNISOLONE | Its record names the disease | ClinicalTrials.gov | |
| NCT03563378 | Effects of Intraoperative Normal Saline vs Lactated Ringer on Outcomes in Pediatric Liver Transplantation | Not applicable | 200 | Biliary Atresia Intrahepatic Syndromic Form | SODIUM CHLORIDE | Its record names the disease | ClinicalTrials.gov | |
| NCT03957629 | Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis | Not applicable | 186 | Hepatitis B, Liver Fibrosis | PEGINTERFERON ALFA-2A, TENOFOVIR DISOPROXIL FUMARATE | Its record names the disease | ClinicalTrials.gov | |
| NCT03920618 | Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF | Not applicable | 150 | Hepatitis B, Acute-On-Chronic Liver Failure | ENTECAVIR, TENOFOVIR ALAFENAMIDE, TENOFOVIR DISOPROXIL FUMARATE | Its record names the disease | ClinicalTrials.gov | |
| NCT06307808 | Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination | 66 | HBV, Kidney Transplantation, Liver Transplantation | BELATACEPT, TACROLIMUS | Its record names the disease | ClinicalTrials.gov | ||
| NCT02689245 | Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure. | Not applicable | 64 | Acute on Chronic Liver Failure | TENOFOVIR | Its record names the disease | ClinicalTrials.gov | |
| NCT07085806 | To Study Effect of Injection Pentoxifylline on Liver Growth After Major Liver Surgery | Not applicable | 60 | Liver Regeneration | PENTOXIFYLLINE | Its record names the disease | ClinicalTrials.gov | |
| NCT01726465 | Methylprednisolone N Acetylcysteine in Hepatic Resections | Phase 2 | 50 | Ischemic Reperfusion Injury, Insufficiency; Hepatic, Postoperative, Liver Tumour | METHYLPREDNISOLONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00225901 | Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure | Phase 1/2 | 16 | Liver Failure, Acute | HEPATOPOIETIN-A | Its record names the disease | ClinicalTrials.gov | |
| NCT07519005 | Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure | Early phase 1 | 1 | Hepatic Failure | ECULIZUMAB, ETANERCEPT, METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, RITUXIMAB, TACROLIMUS | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0100192/trials